Huang Hao

Special PI Program with PKUSZhuang.hao(at)pku.edu.cn

Educational background&Work experience

2016-presentPrinciple Investigator, Peking University, Shenzhen Graduate School

2015-2016Senior Research Scientist (permanent position), Astex Pharmaceuticals, Cambridge, UK

2011-2015Postdoctoral Fellow, Mount Sinai Hospital-Toronto & University of Toronto, Canada

2006-2011 Ph. D in Biochemistry, University of Calgary, Canada (Supervisor: Dr. Hans Vogel)

2004-2005M.Sc. in Chemistry, McMaster University, Canada

1999-2002M.Sc. in Analytical Chemistry, Tsinghua University

1995-1999 B.Sc. in Biology, Sichuan University

Research field

The Hao Huang lab aims to discover small molecular anticancer drug leads.  We employ Fragment Based Drug Discovery (FBDD) and structure based drug design to discover inhibitors targeting important proteins in cancer signaling pathways. In the process of discovering novel anticancer drugs, we use integrative approaches of structural biology, chemical biology and computational chemistry. Specifically, we work on the drug discovery targeting the ubiquitin-proteasome system (UPS). Self-motivated students, postdocs and research associates are encouraged to contact me if you are interested in joining our research lab.